CLABSI Prevention With Tissue Adhesive
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-18
SponsorRabin Medical Center
About this trial
Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
Eligibility criteria
Qualifiers
young age<1y & Congenital Heart Surgery Mortality Category (STAT\STS-EACTS) score 2-5
Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3
preoperative length-of-stay (LOS) >7 days
preoperative ventilator support
Disqualifiers
Patients with on-going bacteremia
patients with pre-existing central-line or peripherally inserted central catheter (PICC)
parental refusal to participate.
Trial design
Treatments tested in this trial
- 2-octyl cyanoacrylate based topical skin adhesive
Treatment groups
600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov